Department of Anesthesiology, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.
Department of Anesthesiology, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.
Knee. 2024 Oct;50:107-114. doi: 10.1016/j.knee.2024.07.023. Epub 2024 Aug 16.
Adductor canal block and periarticular infiltration analgesia (PIA) have been shown to relieve pain in total knee arthroplasty (TKA) effectively. However, their analgesic effectiveness has some limitations. Thus, we considered a novel blocking site that could achieve analgesia without affecting the muscle strength of the lower limbs.
Seventy-two patients undergoing primary unilateral total knee arthroplasty were randomized into two groups. One group was treated with adductor canal and popliteal plexus (APB) combined with interspace between the popliteal artery and posterior capsule of the knee (iPACK) and local infiltration anesthesia (LIA) and the other was treated with PIA. The primary outcomes included postoperative pain, as assessed by the visual analog scale (VAS), and the consumption of oral tramadol. Secondary outcomes included functional recovery and daily ambulation distance. Tertiary outcomes included postoperative adverse effects.
The APB group had lower VAS scores after surgery at rest and during motion. Compared with the PIA group, the walking distance of the APB group on the second day was greater. The muscle strength of the APB group was lower than that of the PIA group at the early stage. Patients in the APB group also consumed less tramadol than those in the PIA group. There was no difference in the incidence of adverse events between the two groups.
APB combined with iPACK and LIA is a novel block for TKA, and it can reduce postoperative pain sooner after TKA without affecting postoperative functional recovery or increasing complications.
股神经阻滞和关节周围浸润镇痛(PIA)已被证明可有效缓解全膝关节置换术(TKA)后的疼痛。然而,它们的镇痛效果存在一些局限性。因此,我们考虑了一种新的阻滞部位,它可以在不影响下肢肌肉力量的情况下实现镇痛。
72 例行单侧初次全膝关节置换术的患者被随机分为两组。一组采用股神经和隐神经(APB)联合膝关节腘动脉和后囊间隙(iPACK)和局部浸润麻醉(LIA)治疗,另一组采用 PIA 治疗。主要结局包括术后疼痛,采用视觉模拟评分(VAS)评估,以及口服曲马多的消耗量。次要结局包括功能恢复和每日活动距离。次要结局包括术后不良反应。
APB 组术后静息和运动时 VAS 评分较低。与 PIA 组相比,APB 组术后第 2 天的步行距离更大。APB 组的肌肉力量在早期低于 PIA 组。APB 组患者的曲马多消耗量也少于 PIA 组。两组不良反应发生率无差异。
APB 联合 iPACK 和 LIA 是 TKA 的一种新的阻滞方法,它可以在不影响术后功能恢复或增加并发症的情况下,更早地减轻 TKA 后的术后疼痛。